Mass spectrometry to classify non-small-cell lung cancer patients for clinical outcome after treatment with epidermal growth factor receptor tyrosine kinase inhibitors: a multicohort cross-institutional study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples